Whole blood-based measurement of SARS-CoV-2-specific T cell responses reveals asymptomatic infection and vaccine efficacy in healthy subjects and patients with solid organ cancers (2021)

First Author: Scurr M

Attributed to: A UK underpinning platform to study immunology and immunopathology of COVID-19:The UK Coronavirus Immunology Consortium funded by COVID

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1101/2021.06.02.21258218

Publication URI: http://dx.doi.org/10.1101/2021.06.02.21258218

Type: Preprint